September 16, 2025 17:10 ET | Source: Theratechnologies MONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”)…
LONDON, Sept. 10, 2025 /PRNewswire/ -- Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that…
September 13, 2025 00:21 ET | Source: Sylogist Ltd. CALGARY, Alberta, Sept. 13, 2025 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX:…
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025 NANTES, France, September…
September 03, 2025 21:47 ET | Source: Mesoblast Limited NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…
Revenue Up 15% to $6.24 Billion; Operating Cash Flow Up 20% to $1.42 Billion SHANGHAI, Aug. 28, 2025 /PRNewswire/ --…
TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage…
SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…
CLEVELAND, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today…
The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting…